Concepedia

Author

Michela Tebaldi

Istituti di Ricovero e Cura a Carattere ScientificoORCID

Also Known As

M. Tebaldi, Michela Tebaldi

47

Publications

657

Citations

13

H-Index

29

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere ScientificoIstituto Scientifico Romagnolo per lo Studio e la Cura dei TumoriOspedale G.B. Morgagni - L.PierantoniUniversity of FerraraOspedale Infermi di Rimini
MT

About

Michela Tebaldi is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, pathology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

288

2

Immunology

2

2

67

3

Public Health

1

1

81

4

Cell Biology

1

1

50

5

Obstetrics

1

1

81

Michela Tebaldi

×

16

Publications

618

Citations

13

H-Index

YearCitations

Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells

Mara Bonelli, Graziana Digiacomo, Claudia Fumarola,

Neoplasia

2017

102

Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer

Gianluca Tedaldi, Michela Tebaldi, Valentina Zampiga,

Oncotarget

2017

81

Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data

Valentina Casadio, Daniele Calistri, Michela Tebaldi,

Urologic Oncology Seminars and Original Investigations

2012

79

Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma

Michele Zanoni, Alba Clara Sarti, Alice Zamagni,

Cell Death and Disease

2022

50

Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer

Chiara Arienti, Michele Zanoni, Sara Pignatta,

Oncotarget

2016

49

DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach

Valentina Casadio, Chiara Molinari, Daniele Calistri,

Journal of Experimental & Clinical Cancer Research

2013

46

ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients

Sara Ravaioli, Michela Tebaldi, Eugenio Fonzi,

Cell Transplantation

2020

40

Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations

Giorgia Simonetti, Carlo Mengucci, Antonella Padella,

Leukemia

2021

33

Estrogen and Androgen Receptor Inhibitors: Unexpected Allies in the Fight Against COVID-19

Sara Bravaccini, Eugenio Fonzi, Michela Tebaldi,

Cell Transplantation

2021

27

Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition

Gianluca Tedaldi, Francesca Pirini, Michela Tebaldi,

Cancers

2019

24

Page 1